Nektar Therapeutics
Assets & Liabilities
| Fiscal Year | Total Liabilities | Total Assets | Cash on Hand |
|---|---|---|---|
| FY2019 | $572.0M | $1.98B | $96.4M |
| FY2020 | $461.5M | $1.54B | $199.0M |
| FY2021 | $437.7M | $1.12B | $25.2M |
| FY2022 | $344.0M | $710.6M | $88.2M |
| FY2023 | $267.0M | $398.0M | $35.3M |
Assets & Liabilities
| Fiscal Year | Total Liabilities | Total Assets | Cash on Hand |
|---|---|---|---|
| FY2019 | $572.0M | $1.98B | $96.4M |
| FY2020 | $461.5M | $1.54B | $199.0M |
| FY2021 | $437.7M | $1.12B | $25.2M |
| FY2022 | $344.0M | $710.6M | $88.2M |
| FY2023 | $267.0M | $398.0M | $35.3M |